Literature DB >> 19837381

Intravitreous vascular endothelial growth factor and hypoxia-inducible factor 1a in patients with proliferative diabetic retinopathy.

Xiaoqin Wang1, Guibo Wang, Yi Wang.   

Abstract

PURPOSE: To determine vascular endothelial growth factor (VEGF) and hypoxia-inducible factor 1a (HIF-1a) in the vitreous fluid of patients with proliferative diabetic retinopathy (PDR).
DESIGN: Observational case-control study.
METHODS: Serum and vitreous fluid samples were obtained during vitrectomy from 42 eyes of diabetic patients with PDR (17 type I and 25 type II diabetes mellitus) and from 23 eyes of nondiabetic patients. Retinopathy of 19 diabetic patients was graded as active and the other 23 graded as quiescent according to retinal neovascularization. VEGF and HIF-1a of serum and vitreous fluid samples were measured by enzyme-linked immunosorbent assay.
RESULTS: Both intravitreous VEGF and HIF-1a were higher in diabetic patients with PDR than in control subjects (P < .01 and P < .01, respectively). After adjusting for total intravitreous protein (TP) concentration, intravitreous VEGF/TP and HIF-1a/TP in diabetic patients remained significantly higher too. Correlations between intravitreous VEGF and HIF-1a and intravitreous VEGF/TP and HIF-1a/TP were observed in diabetic patients with PDR (r = 0.730; P < .01; r = 0.531; P < .01, respectively) but not in control subjects. Both intravitreous VEGF and HIF-1a were higher in diabetic patients with active PDR than in those with quiescent PDR (P < .01 and P < .05, respectively). Intravitreous VEGF/TP in patients with active PDR remained higher (P < .05). Correlation between intravitreous VEGF and HIF-1a, as well as correlation between intravitreous VEGF/TP and HIF-1a/TP, were observed in diabetic patients with active PDR and those with quiescent PDR but not observed in control subjects.
CONCLUSIONS: Intravitreous VEGF and HIF-1a in diabetic patients with PDR are increased and related mutually. VEGF and HIF-1a, especially VEGF, are associated with the angiogenesis of PDR.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19837381     DOI: 10.1016/j.ajo.2009.07.007

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  53 in total

1.  Cysteine-rich 61 (CYR61) is up-regulated in proliferative diabetic retinopathy.

Authors:  Xiao Zhang; Weihong Yu; Fangtian Dong
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-12-13       Impact factor: 3.117

2.  Vitamin D insufficiency in diabetic retinopathy.

Authors:  John F Payne; Robin Ray; David G Watson; Cecile Delille; Eva Rimler; Julia Cleveland; Michael J Lynn; Vin Tangpricha; Sunil K Srivastava
Journal:  Endocr Pract       Date:  2012 Mar-Apr       Impact factor: 3.443

Review 3.  Interactions between nitric oxide and hypoxia-inducible factor signaling pathways in inflammatory disease.

Authors:  Nels Olson; Albert van der Vliet
Journal:  Nitric Oxide       Date:  2011-01-01       Impact factor: 4.427

4.  Role of pericytes in the retina.

Authors:  G S P Santos; P H D M Prazeres; A Mintz; A Birbrair
Journal:  Eye (Lond)       Date:  2017-11-10       Impact factor: 3.775

Review 5.  Dietary hyperglycemia, glycemic index and metabolic retinal diseases.

Authors:  Chung-Jung Chiu; Allen Taylor
Journal:  Prog Retin Eye Res       Date:  2010-09-22       Impact factor: 21.198

6.  Adenoviral 15-lipoxygenase-1 gene transfer inhibits hypoxia-induced proliferation of retinal microvascular endothelial cells in vitro.

Authors:  Ying Yan; Tao He; Ying Shen; Xiao Chen; Bo Diao; Zhi Li; Qing Liu; Yi-Qiao Xing
Journal:  Int J Ophthalmol       Date:  2012-10-18       Impact factor: 1.779

7.  Angiogenic Factors and Cytokines in Diabetic Retinopathy.

Authors:  Steven F Abcouwer
Journal:  J Clin Cell Immunol       Date:  2013

8.  Intravitreous high expression level of netrin-1 in patients with proliferative diabetic retinopathy.

Authors:  Jiaolian Liu; Xiaobo Xia; Siqi Xiong; Yunzheng Le; Huizhuo Xu
Journal:  Eye Sci       Date:  2011-06

Review 9.  A review of anti-VEGF agents for proliferative diabetic retinopathy.

Authors:  P Osaadon; X J Fagan; T Lifshitz; J Levy
Journal:  Eye (Lond)       Date:  2014-02-14       Impact factor: 3.775

Review 10.  Hypoxia-inducible factors and diabetes.

Authors:  Jenny E Gunton
Journal:  J Clin Invest       Date:  2020-10-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.